Skip to main content
. Author manuscript; available in PMC: 2017 May 22.
Published in final edited form as: Cancer Causes Control. 2015 Nov 30;27(2):229–236. doi: 10.1007/s10552-015-0700-7

Table 3. Associations of weight change from pre-diagnosis to 18-month post-diagnosis with TNBC survival, stratified by pre-diagnostic BMI and menopausal status.

Weight change from pre-diagnosis to post-diagnosis a

Stable within 5% Gain (≥ 5 %) Loss (≥ 5 %) P for interaction



Total/Event HR Total/Event HR (95% CI) Total/Event HR (95% CI)
Total mortality
 Total 247/45 1.00 184/38 1.26(0.80,2.00) 42/27 2.08(1.25,3.46)
 Stratified by pre-diagnostic BMI
  <24.0 121/19 1.00 142/25 1.13(0.60,2.13) 27/12 1.73(0.74,4.04)
  ≥24.0 125/25 1.00 42/13 1.88(0.92,3.85) 42/15 2.15(1.09,4.26) 0.48
 Stratified by menopausal status at baseline
  Premenopausal 99/8 1.00 118/24 2.84(1.23,6.58) 20/7 6.22(2.13,8.13)
  Postmenopausal 148/37 1.00 66/14 0.95(0.50,1.80) 49/20 1.64(0.91,2.98) 0.46

Recurrence/disease-specific mortality
 Total 247/37 1.00 184/35 1.32(0.81,2.15) 69/25 2.50(1.45,4.30)
 Stratified by pre-diagnostic BMI a
  <24.0 121/17 1.00 142/25 1.30(0.67,2.50) 27/10 1.80(0.72,4.52)
  ≥24.0 125/20 1.00 42/10 1.91(0.85,4.31) 42/15 2.65(1.28,5.46) 0.86
 Stratified by menopausal status at baseline
  Premenopausal 99/9 1.00 118/23 2.38(1.08,5.25) 20/8 7.26(2.62,20.11)
  Postmenopausal 148/28 1.00 65/12 1.01(0.50,2.05) 49/17 1.92(0.98,3.79) 0.59
a

HRs from Cox regression models and adjusted for age at diagnosis (continuous variable), education (<high school, high school, >high school), Charlson comorbidity index (0, ≥ 1), menopausal status at baseline (yes, no), exercise participation at baseline (yes, no), type of surgery received, chemotherapy (yes, no), radiotherapy (yes, no), and TNM stage (I, II, III, unknown)